iasusa
iasusa
Podcast by iasusa
No dejes de visitar la web del podcast y apoyar a su creador: soundcloud.com
Autor
iasusa
Categoría
Web del podcast
Último episodio
21 de oct. de 2026
¿Dónde escuchar?
Podcasts en la app Replaio Radio Muy prontoLos podcasts llegarán muy pronto a la app. Instálala ahora y sé el primero en descubrir una forma totalmente nueva de vivir los podcasts
Episodios
Controversies In Managing Sexually Transmitted Infections: A Case-Based Panel Discussion 07.04.2022 1:11:28
Jeffrey Lennox, MD The IAS–USA 30th Annual Update on HIV Management in Atlanta, Georgia April 8, 2022 1 hour, 11 minutes, and 28 seconds
Special Panel 40 Years Later: Looking Back at the Beginning of the HIV/AIDS Epidemic in Atlanta, GA 06.04.2022 1:03:41
Moderators: Jeffrey Lennox, MD, and Michael Saag, MD Panelists: James Curran, MD, MPH, Jonathan Kaplan, MD, Harold Jaffe, MD, David Rimland, MD, and Melanie Thompson, MD The IAS–USA 30th Annual Update on HIV Management in Atlanta, Georgia April 8, 2022 1 hour, 3 minutes, and 41 seconds
(April 1, 2022) The Latest on Omicron Subvariant BA.2 in the US, 4th Dose, and Vaccine in Children 05.04.2022 1:01:18
The Latest on Omicron Subvariant BA.2 in the US, 4th Dose of COVID-19 Vaccine, and Vaccination in Children Broadcast: Friday, March 31, 2022 Discussants: Yvonne Maldonado, MD, Peter Chin-Hong, MD, and Michael S. Saag, MD Moderator: Paul A. Volberding, MD
Antiretroviral Therapy Cases From the Clinic(ians): A Case-Based Presentation and Panel Discussion 05.04.2022 1:03:13
Michael S. Saag, MD The IAS–USA 30th Annual Update on HIV Management in Atlanta, Georgia April 8, 2022 1 hour, 3 minutes, and 13 seconds
In Case You Missed It: Updates From CROI 2022 and Beyond 04.04.2022 42:35
Rajesh T. Gandhi, MD The IAS–USA 30th Annual Update on HIV Management in Atlanta, Georgia April 8, 2022 42 minutes and 35 seconds
(February 4, 2022) Latest Update on COVID-19 Vaccines and Scientific Leaders’ Perspectives 09.02.2022 1:00:56
(February 4, 2022) Latest Update on COVID-19 Vaccines and Scientific Leaders’ Perspectives by iasusa
Investigational Antiretroviral Drugs and Strategies 04.01.2022 39:14
Constance A. Benson, MD HIV, COVID-19, and Sexually Transmitted Infections: Update and Implications for Practice November 5, 2021 39 minutes and 14 seconds
Welcome 04.01.2022 4:19
Welcome by iasusa
Current Options for Treating and Managing COVID-19 04.01.2022 45:22
Rajesh T. Gandhi, MD HIV, COVID-19, and Sexually Transmitted Infections: Update and Implications for Practice November 5, 2021 45 minutes and 22 seconds
COVID-19 Interactions with Other Viruses 04.01.2022 41:35
Robert T. Schooley, MD HIV, COVID-19, and Sexually Transmitted Infections: Update and Implications for Practice November 5, 2021 41 minutes and 35 seconds
State-of-the-art Cases on Antiretroviral Therapy 04.01.2022 46:57
Monica Gandhi, MD, MPH HIV, COVID-19, and Sexually Transmitted Infections: Update and Implications for Practice November 5, 2021 46 minutes and 57 seconds
Updated CDC Guidelines on Testing and Treating Sexually Transmitted Infections 04.01.2022 40:08
Connie L. Celum, MD, MPH HIV, COVID-19, and Sexually Transmitted Infections: Update and Implications for Practice November 5, 2021 40 minutes and 8 seconds
In Case You Missed It: Updates From Recent Publications and Meetings 04.01.2022 28:09
Roger J. Bedimo, MD, MS HIV, COVID-19, and Sexually Transmitted Infections: Update and Implications for Practice November 5, 2021 28 minutes and 9 seconds
Expert Roundtable Discussion 04.01.2022 26:51
Moderated by Monica Gandhi, MD, and Robert T. Schooley, MD Panelists: Constance A. Benson, MD, Connie L. Celum, MD, MPH, Roger J. Bedimo, MD, MS, Meredith E. Clement, MD HIV, COVID-19, and Sexually Transmitted Infections: Update and Implications for Practice November 5, 2021 26 minutes and 51 seconds
(December 3, 2021) Omicron Variant, Therapeutics, and COVID-19 in People Who Are Immunocompromised 06.12.2021 1:01:46
(December 3, 2021) Omicron Variant, Therapeutics, and COVID-19 in People Who Are Immunocompromised by iasusa
Closing 18.11.2021 0:45
Closing PrEParing for PrEP: From Policy to Implementation November 19, 2021 45 seconds
Expert Roundtable Discussion 18.11.2021 54:38
Moderated by Henry Masur, MD, and Michael S. Saag, MD Panelists: Susan P. Buchbinder, MD; Raphael J. Landovitz, MD, MSc; Jean-Michel Molina, MD, Marina Klein, MD, MS, and Hyman Scott, MD, MPH PrEParing for PrEP: From Policy to Implementation November 19, 2021 54 minutes and 48 seconds
Leveraging Administrative and Governmental Policies to Improve PrEP Utilization 18.11.2021 27:20
Jeffrey S. Crowley, MPH PrEParing for PrEP: From Policy to Implementation November 19, 2021 27 minutes and 20 seconds
How to Reach the Hard to Reach: Policies and Strategies to Address Access to PrEP 18.11.2021 29:24
Monica Gandhi, MD, MPH PrEParing for PrEP: From Policy to Implementation November 19, 2021 29 minutes and 24 seconds
Ending the HIV Epidemic: The Impact of PrEP 18.11.2021 26:32
Susan P. Buchbinder, MD PrEParing for PrEP: From Policy to Implementation November 19, 2021 26 minutes and 32 seconds
Question-and Answer Panel Session 18.11.2021 16:50
Question-and Answer Panel Session PrEParing for PrEP: From Policy to Implementation November 19, 2021 16 minutes and 50 seconds
Assessing and Monitoring Persons Interested in Starting and Continuing PrEP 18.11.2021 26:37
Hyman Scott, MD, MPH PrEParing for PrEP: From Policy to Implementation November 19, 2021 26 minutes and 37 seconds
Strategies to Optimize PrEP: Schedules, Formulations, and Innovative Approaches 18.11.2021 25:13
Jean-Michel Molina, MD PrEParing for PrEP: From Policy to Implementation November 19, 2021 25 minutes and 13 seconds
PrEP: State of the Science Overview 18.11.2021 28:46
Raphael J. Landovitz, MD, MSc PrEParing for PrEP: From Policy to Implementation November 19, 2021 28 minutes and 46 seconds
Welcome 18.11.2021 11:28
Welcome PrEParing for PrEP: From Policy to Implementation November 19, 2021 11 minutes and 28 seconds
Podcasts similares
Replaio no es editor de podcasts; los nombres de los programas, las portadas y el audio pertenecen a sus autores y se distribuyen a través de canales RSS públicos